Médecine

Paramédical

Autres domaines


S'abonner

Association between rosacea and cardiometabolic disease: A systematic review and meta-analysis - 10/10/20

Doi : 10.1016/j.jaad.2020.04.113 
Qi Chen, MD a, b, c, Xiao Shi, MD d, Yan Tang, MD, PhD a, b, c, Ben Wang, MD, PhD a, b, c, Hong-fu Xie, MD, PhD a, b, c, Wei Shi, MD, PhD a, b, c, , Ji Li, MD, PhD a, b, c,
a Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China 
b National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China 
c Key Laboratory of Organ Injury, Aging and Regenerative Medicine of Hunan Province, Changsha, China 
d Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, China 

Correspondence to: Ji Li, MD, PhD, Department of Dermatology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, People's Republic of China 410008.Department of DermatologyXiangya HospitalCentral South University87 Xiangya RdChangshaHunan410008People's Republic of ChinaWei Shi, MD, PhD, Department of Dermatology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, People's Republic of China 410008.Department of DermatologyXiangya HospitalCentral South University87 Xiangya RdChangshaHunan410008People's Republic of China

Abstract

Background

Rosacea is recognized as a chronic inflammatory cutaneous disorder associated with multiple systemic illnesses. However, the association between rosacea and cardiometabolic disease (CMD) remains controversial.

Objective

To evaluate the association between rosacea and CMD by a systematic review and meta-analysis.

Methods

A comprehensive search of studies published before October 16, 2019, was performed in databases of PubMed, Embase, Cochrane Library, and Web of Science. The pooled risk ratios or standardized mean differences were calculated.

Results

Thirteen studies were included, representing 50,442 patients with rosacea. Patients with rosacea had higher prevalence of dyslipidemia, higher prevalence of hypertension, higher total cholesterol, higher low-density lipoprotein, higher triglycerides, higher systolic blood pressure, higher diastolic blood pressure, and higher fasting blood glucose. Rosacea was not associated with ischemic heart disease, stroke, diabetes, and high-density lipoprotein.

Limitations

No subgroup analysis could be performed according to the subtypes and severity of rosacea.

Conclusions

Rosacea showed a correlation with hypertension and dyslipidemia but not with ischemic heart disease, stroke, or diabetes. We advocate screening for CMD indicators among patients with rosacea, which may be helpful for diagnosis and appropriate treatment at an early stage of disease.

Le texte complet de cet article est disponible en PDF.

Key words : cardiometabolic disease, cardiovascular disease, diabetes, dyslipidemia, hypertension, meta-analysis, rosacea

Abbreviations used : CCB, CI, CMD, CVD, FBG, HDL, IHD, LDL, RR, SMD, TC, TG


Plan


 Drs Chen and Shi contributed equally to this paper.
 Funding sources: Supported by the National Natural Science Foundation of China (grant nos. 81874251), the National Natural Science Foundation of China (grant nos. 81673086), the National Natural Science Foundation of China (grants nos. 81602784), and the National Natural Science Foundation of China (the Major Research Plan, Training Program, grant nos. 91749114).
 Conflicts of interest: None disclosed.
 IRB approval status: Not applicable.
 Reprints not available from the authors.


© 2020  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 83 - N° 5

P. 1331-1340 - novembre 2020 Retour au numéro
Article précédent Article précédent
  • Drug reaction with eosinophilia and systemic symptoms (DRESS) in the pediatric population: A systematic review of the literature
  • Grace Y. Kim, Katelyn R. Anderson, Dawn M.R. Davis, Jennifer L. Hand, Megha M. Tollefson
| Article suivant Article suivant
  • The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort study
  • John W. Frew, Kristina Navrazhina, David Grand, Mary Sullivan-Whalen, Patricia Gilleaudeau, Sandra Garcet, Jonathan Ungar, James G. Krueger

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.